Transgenic oncogene mice. Tumor phenotype predicts genotype
about
Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2Proteotypic classification of spontaneous and transgenic mammary neoplasmsEvolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotypeExpression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancerThe pathology of EMT in mouse mammary tumorigenesis.Dietary lipids and calorie restriction affect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic miceOf mice and women: A short history of mouse mammary cancer research with an emphasis on the paradigms inspired by the transplantation method.Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies.Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.Three interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells.Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors.c-myc amplifications in primary breast carcinomas and their local recurrences.Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-alpha. Characterization of mammary gland and skin proliferations.Changes in frequency, morphology, and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene.Multiple tumor types appear in a transgenic mouse with the ras oncogene.Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis.Mouse mammary tumor virus/v-Ha-ras transgene-induced mammary tumors exhibit strain-specific allelic loss on mouse chromosome 4Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR.Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor PhenotypeKinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy.Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.Pathobiology of the 129:Stat1 -/- mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotypeGenomic pathology for genomic biology.Aging Mouse Models Reveal Complex Tumor-Microenvironment Interactions in Cancer Progression.
P2860
Q24672372-7A3CA34F-9CA9-48EB-B48A-2804EC04A402Q24795869-E1145AF8-383C-4822-87A8-38EE82A21831Q24801345-B39250B7-4355-4B5F-8E09-A02D4B75A6D2Q28570541-A174047E-3E4D-438E-9ECF-AD8C2437E23EQ33890758-67FC4528-0848-4970-8A6C-F761C4DD54B2Q33915129-1E3082EF-44E5-45BC-9E5E-5BF8AE7A4739Q34132434-DB3A4E2C-AC4F-4179-B0E7-4D2DF93DF95DQ34149928-69240337-A944-4E71-9B80-3D7593D40A8FQ34205443-4F44FC22-C363-4250-AE24-F6B661CD8537Q34792452-B62B3A13-CCF0-428F-B9FB-26547DB5EAFDQ35683502-B4F128BF-7704-49ED-B85A-58B232514328Q35748204-F95D2B0A-9FE7-4026-9B44-10E557762382Q35748541-2A0FF8D5-CAB7-4E0F-9EE7-07CF76093988Q35769894-BED08D0C-A064-4096-A3C1-F0924EEBB935Q35789027-D92442F1-EC09-4289-A720-D653027DD3D1Q35831666-616FC331-F150-4B46-B7C2-0DF56F5AD6A8Q35832372-836EE981-7ABE-41A3-B187-E6A4481913A3Q35832674-48765201-C5DB-4F29-B044-C1EF225DF193Q35964137-7298CC57-A09E-4082-A817-1229B92E4BE5Q36553814-CD8AFDD9-2AB4-4602-A538-B8C5779B4CB0Q36677182-22498C40-B37C-415C-8C03-A44122D017DEQ36727086-019E8A34-2647-4D68-8E01-CFD03504D2D2Q37031949-10B23463-82C1-47DB-87E4-0D00E8D87B7EQ37208778-D22727B5-C54C-4203-9A32-F5F2E151A5DFQ37356573-7090F411-2BE1-42A7-A797-77DAAE1278EFQ41594948-FD3A1D81-AE42-4689-B3D5-4E8337AE6067Q42861153-4D802976-ABF3-4550-84ED-5DACAC73FCFFQ52322881-DC9ECAF5-11E3-4FDB-90AE-6E961E5DE45B
P2860
Transgenic oncogene mice. Tumor phenotype predicts genotype
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Transgenic oncogene mice. Tumor phenotype predicts genotype
@ast
Transgenic oncogene mice. Tumor phenotype predicts genotype
@en
type
label
Transgenic oncogene mice. Tumor phenotype predicts genotype
@ast
Transgenic oncogene mice. Tumor phenotype predicts genotype
@en
prefLabel
Transgenic oncogene mice. Tumor phenotype predicts genotype
@ast
Transgenic oncogene mice. Tumor phenotype predicts genotype
@en
P2093
P2860
P1476
Transgenic oncogene mice. Tumor phenotype predicts genotype
@en
P2093
P2860
P304
P407
P577
1991-09-01T00:00:00Z